Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

A careful disorderliness in the proteome: sites for interaction and targets for future therapies.

Russell RB, Gibson TJ.

FEBS Lett. 2008 Apr 9;582(8):1271-5. doi: 10.1016/j.febslet.2008.02.027. Review.

2.

Target profiling of small molecules by chemical proteomics.

Rix U, Superti-Furga G.

Nat Chem Biol. 2009 Sep;5(9):616-24. doi: 10.1038/nchembio.216. Review.

PMID:
19690537
3.

Interaction between intrinsically disordered proteins frequently occurs in a human protein-protein interaction network.

Shimizu K, Toh H.

J Mol Biol. 2009 Oct 9;392(5):1253-65. doi: 10.1016/j.jmb.2009.07.088.

PMID:
19660471
4.

Surface plasmon resonance mass spectrometry in proteomics.

Visser NF, Heck AJ.

Expert Rev Proteomics. 2008 Jun;5(3):425-33. doi: 10.1586/14789450.5.3.425. Review.

PMID:
18532910
5.

A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease.

Han CL, Chien CW, Chen WC, Chen YR, Wu CP, Li H, Chen YJ.

Mol Cell Proteomics. 2008 Oct;7(10):1983-97. doi: 10.1074/mcp.M800068-MCP200.

6.

Protein-protein interactions as targets for small-molecule therapeutics in cancer.

White AW, Westwell AD, Brahemi G.

Expert Rev Mol Med. 2008 Mar 19;10:e8. doi: 10.1017/S1462399408000641. Review.

PMID:
18353193
7.

Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins.

Zolla L.

Drug Discov Today. 2008 Dec;13(23-24):1042-51. doi: 10.1016/j.drudis.2008.09.013. Review.

PMID:
18973825
8.

Proteomics of breast cancer: the quest for markers and therapeutic targets.

Hondermarck H, Tastet C, El Yazidi-Belkoura I, Toillon RA, Le Bourhis X.

J Proteome Res. 2008 Apr;7(4):1403-11. doi: 10.1021/pr700870c. Review.

PMID:
18311906
9.

Mining the oncoproteome and studying molecular interactions for biomarker development by 2DE, ChIP and SPR technologies.

Ahmed FE.

Expert Rev Proteomics. 2008 Jun;5(3):469-96. doi: 10.1586/14789450.5.3.469. Review.

PMID:
18532914
10.

Moonlighting proteins--an update.

Jeffery CJ.

Mol Biosyst. 2009 Apr;5(4):345-50. doi: 10.1039/b900658n. Review.

PMID:
19396370
11.

Antibody technology in proteomics.

Saerens D, Ghassabeh GH, Muyldermans S.

Brief Funct Genomic Proteomic. 2008 Jul;7(4):275-82. doi: 10.1093/bfgp/eln028. Review.

PMID:
18586755
12.

Recent developments in proteome informatics for mass spectrometry analysis.

Wright JC, Hubbard SJ.

Comb Chem High Throughput Screen. 2009 Feb;12(2):194-202. Review.

PMID:
19199887
13.

Recent developments in microwave-assisted protein chemistries - can this be integrated into the drug discovery and validation process?

Sandoval WN, Pham VC, Lill JR.

Drug Discov Today. 2008 Dec;13(23-24):1075-81. doi: 10.1016/j.drudis.2008.08.007. Review.

PMID:
18801456
14.

Plant proteomics.

Sarnighausen E, Reski R.

Methods Mol Biol. 2008;484:29-44. doi: 10.1007/978-1-59745-398-1_3.

PMID:
18592171
15.

Microbial community proteomics: elucidating the catalysts and metabolic mechanisms that drive the Earth's biogeochemical cycles.

Wilmes P, Bond PL.

Curr Opin Microbiol. 2009 Jun;12(3):310-7. doi: 10.1016/j.mib.2009.03.004. Review.

PMID:
19414280
16.

8th Siena meeting. From genome to proteome: integration and proteome completion.

Godovac-Zimmermann J.

Expert Rev Proteomics. 2008 Dec;5(6):769-73. doi: 10.1586/14789450.5.6.769.

PMID:
19086856
17.

Druggable targets and targeted drugs: enhancing the development of new therapeutics.

Billingsley ML.

Pharmacology. 2008;82(4):239-44. doi: 10.1159/000157624. Review.

18.

An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes.

Jia L, Zhang L, Shao C, Song E, Sun W, Li M, Gao Y.

PLoS One. 2009;4(4):e5146. doi: 10.1371/journal.pone.0005146.

19.

From Genome to Proteome: Integration and proteome completion - 8th Siena Meeting.

Wheelock AM, Wheelock CE.

IDrugs. 2008 Nov;11(11):799-802.

PMID:
18988122
20.

Phosphoproteomic analysis of the mouse brain cytosol reveals a predominance of protein phosphorylation in regions of intrinsic sequence disorder.

Collins MO, Yu L, Campuzano I, Grant SG, Choudhary JS.

Mol Cell Proteomics. 2008 Jul;7(7):1331-48. doi: 10.1074/mcp.M700564-MCP200.

Items per page

Supplemental Content

Support Center